4 Total 18–24 25–34 35–44 45–54 55–64 ≥65 Urban Rural Total 18–24 25–34 35–44 45–54 55–64 ≥65 Urban Rural Total Urban Rural Total Urban Rural n/N 401/906 0/14 2/51 27/99 94/220 109/215 169/307 230/484 171/422 n/N 352/906 0/14 2/51 20/99 85/220 94/215 151/307 202/484 150/422 70/352 49/202 21/150 70/906 49/484 21/422 International Journal of Hypertension Table 3: Arterial hypertension awareness in SEPHAR study. Total Men Women Table 4: Rate of arterial hypertension treatment and control in SEPHAR study. Total Men Women % n/N % Awareness of hypertension splitted by age groups 44.26% 147/425 34.58% 0% 0/9 0% 3.92% 0/34 0% 27.27% 14/51 27.45% 42.72% 31/102 30.39% 50.69% 30/77 38.96% 55.04% 72/152 47.36% Awareness of hypertension splitted by area of residence 47.52% 84/226 37.16% 40.52% 63/199 31.65% % n/N % Treated cases of hypertension splitted by age groups 38.85% 128/425 30.11% 0% 0/9 0% 3.92% 0/34 0% 20.2% 9/51 17.64% 38.63% 30/102 29.41% 43.72% 24/77 31.16% 49.18% 65/152 42.76% Treated cases of hypertension splitted by area of residence 41.73% 73/226 32.3% 35.54% 55/199 27.64% Hypertension control for treated patients 19.88% 27/128 21.09% Hypertension control for treated patients by area of residence 24.25% 19/73 26.02% 14% 8/55 14.54% General control of hypertension 7.72% 27/425 6.35% General control of hypertension by area of residence 10.12% 19/226 8.4% 4.97% 8/199 4.02% n/N 254/481 0/5 2/17 13/48 63/118 79/138 97/155 146/258 108/223 n/N 224/481 0/5 2/17 11/48 55/118 70/138 86/155 129/258 95/223 43/224 30/129 13/95 43/481 30/258 13/223 % 52.8% 0% 11.76% 27.08% 53.38% 57.24% 62.58% 56.58% 48.43% % 46.56% 0% 11.76% 22.91% 46.61% 50.72% 55.48% 50% 42.6% 19.19% 23.25% 13.68% 8.93% 11.62% 5.82% during clinical visits), age of subjects enrolled, number of visits for the measurements of blood pressure, adaptation of cuﬀ size for the arm circumference, or the period of time when the survey has been done. Therefore, a special attention will be focused on the comparison with the results of NATPOL PLUS, a study that has been realized with the same methodology in Poland. Our data are indicating a 44,92% prevalence of the AHT in Romania, higher than in Poland, where was estimated at 29% [6, 7]. In general, the rates of AHT are greater in Europe than in the United States (28%), Canada (27%), or Asian countries including China (20%) or Korea (22,9%) [4, 10– 12]. The prevalence of AHT in Romania can be integrated between lower values in Europe like those in Greece (31,1), Sweden (38%), Italy (38%), United Kingdom (42%), Czech Republic (42%), or Portugal (42,1%) and higher values such as those from Spain (47%) or Germany (55%) [4, 13–15]. For each gender, AHT was rising in successive age groups. In our study AHT was signiﬁcantly more prevalent in men. The ratio of AHT frequency between the two genders is varying from one study to another and in Poland was greater in women. There are not many studies analyzing